This project is currently (1) developing a novel, ultra-small footprint VF device for use during expeditionary spaceflight (FY18-19), and in FY19 proposes to (2) complete clinical validations to ensure performance is comparable to large-scale COTS VF devices and (3) complete initial operational testing. This device is intended to detect, monitor progression, and guide medical intervention of severe SANS cases during long-duration missions, as well as detect neuro-ocular pathology near the battlefield, aboard U.S. Navy ships, and during humanitarian missions. It will transition into space and terrestrial usage in FY20-21.
More »It's been discovered that all - or nearly all - long-duration crewmembers present with one or more signs of Spaceflight Associated Neuro-ocular Syndrome (SANS; formerly VIIP). No small-footprint devices exist to test the impact of SANS on crewmember visual performance during expeditionary spaceflight. Visual field (VF) testing is a well-established, non-invasive test used to assess the effect of neurological pathology on visual function.
More »Organizations Performing Work | Role | Type | Location |
---|---|---|---|
Johnson Space Center (JSC) | Lead Organization | NASA Center | Houston, Texas |
Naval Medical Research Unit Dayton | Supporting Organization | Other US Government | Dayton, Ohio |
Translational Research Institute for Space Health (TRISH) | Supporting Organization | Academia | Houston, Texas |
USAF 711th Human Performance Wing | Supporting Organization | Other US Government | Wright-Patterson Air Force Base, Ohio |
Web Vision Technologies | Supporting Organization | Industry |